Third Harmonic Bio: Board & Compensation Changes Announced
| Field | Detail |
|---|---|
| Company | Third Harmonic Bio, Inc. |
| Form Type | 8-K |
| Filed Date | Apr 22, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation, governance
Related Tickers: THBIO
TL;DR
THBIO board shakeup and comp changes filed 4/21.
AI Summary
Third Harmonic Bio, Inc. announced on April 21, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategy and execution.
Key Numbers
- 001-41498 — SEC File Number (Identifies the company's filing history with the SEC.)
- 83-4553503 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Third Harmonic Bio, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- San Francisco, California (location) — Principal executive offices address
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates changes related to 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', but does not specify the exact roles in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated April 21, 2025.
What is the primary business of Third Harmonic Bio, Inc. according to the filing?
The Standard Industrial Classification code indicates the company is in 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where are Third Harmonic Bio, Inc.'s principal executive offices located?
The principal executive offices are located at 1700 Montgomery Street, Suite 210, San Francisco, California 94111.
What is the filing date of this 8-K report?
The filing date is April 22, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 22, 2025 regarding Third Harmonic Bio, Inc..